» Articles » PMID: 35490243

Using Affected Embryos to Establish Linkage Phase in Preimplantation Genetic Testing for Thalassemia

Overview
Publisher Biomed Central
Date 2022 Apr 30
PMID 35490243
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study aimed to evaluate the ability of next-generation sequencing (NGS) to conduct preimplantation genetic testing (PGT) for thalassemia using affected embryos.

Methods: This study included data from 36 couples who underwent PGT for thalassemia without probands and relative pedigrees. NGS results were compared with prenatal diagnosis results.

Results: Thirty-six couples (29 α-thalassemia and 7 β-thalassemia) underwent 41 PGT cycles (31 α-thalassemia and 10 β-thalassemia). Analysis using NGS produced conclusive results for all biopsied blastocysts (100%, 217/217). One hundred and sixty (73.7%, 160/217) were unaffected by thalassemia. Preimplantation genetic testing for aneuploidy revealed that 112 (70.0%, 112/160) were euploid. Single blastocysts were transferred into the uteri of 34 women (53 frozen embryo transfer [FET] cycles). Thirty-two cycles resulted in clinical pregnancies, with a clinical pregnancy rate of 60.1% (32/53) per FET cycle. Twenty-two cycles (22 couples) resulted in 23 live births, with a live birth rate of 43.4% (23/53; 3 cycles were ongoing pregnancies). All 25 embryos' prenatal diagnosis results and/or thalassemia gene analyses after delivery were concordant with the NGS-PGT results. Seven embryos (21.9%, 7/32) were miscarried before 12 weeks' gestation, and the abortion villus in four showed a normal karyotype and thalassemia results consistent with the NGS-PGT results. Aborted fetus samples from 3 cycles were not available because the pregnancy lasted less than 5 weeks.

Conclusion: NGS can be used to conduct PGT for thalassemia using affected embryos as a reference.

Trial Registration: Retrospectively registered.

Citing Articles

ViLR: a novel virtual long read method for breakpoint identification and direct SNP haplotyping in de novo PGT-SR carriers without a proband.

Xue J, Xie M, Cai J, Kang K, Gu M, Li M Reprod Biol Endocrinol. 2025; 23(1):34.

PMID: 40038676 PMC: 11881346. DOI: 10.1186/s12958-025-01366-3.


Technically feasible solutions to challenges in preimplantation genetic testing for thalassemia: experiences of multiple centers between 2019 and 2022.

Ren Z, Huang P, Wang Y, Yao Y, Ren J, Xu L J Assist Reprod Genet. 2024; 41(11):3225-3235.

PMID: 39256293 PMC: 11621276. DOI: 10.1007/s10815-024-03240-4.


Appropriate whole genome amplification and pathogenic loci detection can improve the accuracy of preimplantation genetic diagnosis for deletional α-thalassemia.

Lan Y, Zhou H, He S, Shu J, Liang L, Wei H Front Endocrinol (Lausanne). 2024; 14:1176063.

PMID: 38523870 PMC: 10957767. DOI: 10.3389/fendo.2023.1176063.


Proband-independent haplotyping based on NGS-based long-read sequencing for detecting pathogenic variant carrier status in preimplantation genetic testing for monogenic diseases.

Zhang P, Zhao X, Li Q, Xu Y, Cheng Z, Yang L Front Mol Biosci. 2024; 11:1329580.

PMID: 38516188 PMC: 10955336. DOI: 10.3389/fmolb.2024.1329580.


Should non-invasive prenatal testing be recommended for patients who achieve pregnancy with PGT?.

Liang Y, Li M, Fei J, Chen Z BMC Pregnancy Childbirth. 2024; 24(1):100.

PMID: 38302865 PMC: 10832195. DOI: 10.1186/s12884-024-06284-7.


References
1.
Handyside A, Kontogianni E, Hardy K, Winston R . Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature. 1990; 344(6268):768-70. DOI: 10.1038/344768a0. View

2.
Harper J, Wilton L, Traeger-Synodinos J, Goossens V, Moutou C, SenGupta S . The ESHRE PGD Consortium: 10 years of data collection. Hum Reprod Update. 2012; 18(3):234-47. DOI: 10.1093/humupd/dmr052. View

3.
Wang H, Ou Z, Chen Z, Yang L, Sun L . Influence of different post-thaw culture time on the clinical outcomes of different quality embryos. Adv Clin Exp Med. 2019; 28(4):523-527. DOI: 10.17219/acem/91010. View

4.
Taher A, Weatherall D, Cappellini M . Thalassaemia. Lancet. 2017; 391(10116):155-167. DOI: 10.1016/S0140-6736(17)31822-6. View

5.
Li Q, Mao Y, Li S, Du H, He W, He J . Haplotyping by linked-read sequencing (HLRS) of the genetic disease carriers for preimplantation genetic testing without a proband or relatives. BMC Med Genomics. 2020; 13(1):117. PMC: 7441613. DOI: 10.1186/s12920-020-00766-1. View